GABAergic modulation of yawning behavior.
The hypothetical modulation by GABAergic neurons of yawning behavior in the rat was explored with GABA-active drugs. Gamma-acetylenic-GABA, a specific inhibitor of GABA-T, increases yawning frequency when injected at a dose of 7 mg/kg. Baclofen, a GABAB agonist (3 mg/kg), inhibits yawning completely; GABA antagonists, bicuculline and picrotoxin, at subconvulsant doses, also decrease yawning. All drugs were injected intraperitoneally with the exception of apomorphine, which was injected subcutaneously. It is suggested that GABAB receptors play a role in yawning behavior by modulating ACh release, and that GABAA receptors may modify yawning frequency by modulating inhibitory influences on ACh neurons.
Doger
E
E
Departamento de Ciencias Fisiológicas, Universidad Autónoma de Puebla, Mexico.
Urbá-Holmgren
R
R
Eguibar
J R
JR
Holmgren
B
B
D000612:4-Aminobutyrate Transaminase / Q000037:antagonists & inhibitors; D000109:Acetylcholine / Q000493:pharmacokinetics; D000480:Alkynes; D000614:Aminocaproates / Q000494:pharmacology; D000818:Animals; D003292:Convulsants / Q000494:pharmacology; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D011963:Receptors, GABA-A / Q000187:drug effects; D015000:Yawning / Q000187:drug effects*; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology*
D000480:Alkynes; D000614:Aminocaproates; D003292:Convulsants; D011963:Receptors, GABA-A; D005680:gamma-Aminobutyric Acid; C013785:4-amino-5-hexynoic acid; D000612:4-Aminobutyrate Transaminase; D000109:Acetylcholine